U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 11-17, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 11-17, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 07/14/2021
Location: Virtual
Subject: National Institute for Innovation in Manufacturing Biopharmaceuticals National Meeting; Speaker: Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, media, and other invited guests

Event Date: 07/14/2021
Location: Virtual
Subject: 2021 STAT Breakthrough Science Summit; Speaker: Fireside Chat
FDA Participant/Group: MICHAEL FELBERBAUM;
Non FDA Participant/Group: Industry, academia, media, and other members of the public

Event Date: 07/15/2021
Location: Virtual
Subject: COVID-19 Vaccine Updates Related to Guillain-Barre Syndrome
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Several stakeholder organizations, healthcare professionals, patient advocacy groups, consumer organizations, national immunization organizations, state and local public health organizations

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 07/14/2021
Location: Virtual
Subject: Emerging Applications on Blockchain Technology
FDA Participant/Group: N/A
Non FDA Participant/Group: Participants across industry, academia, nonprofit, and government

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 07/13/2021
Location: Virtual
Subject: Public Health Risks from Japanese Food Due to Deactivation of Import Alert 99-33
FDA Participant/Group: SEMA HASHEMI, ANNE KIRCHNER, JULIE MOSS, DON PRATER, ERIK METTLER
Non FDA Participant/Group: Officials from Japanese Ministries of Health, Agriculture

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 07/14/2021
Location: Virtual
Subject: The Alliance for a Stronger FDA Board Meeting
FDA Participant/Group: JUDITH MCMEEKIN;
Non FDA Participant/Group: Alliance board members

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 07/14/2021
Location: Virtual
Subject: FDA / Duke-Margolis Roundtable; Understanding Payer Evidentiary Needs for Alzheimer’s
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 07/15/2021
Location: Virtual
Subject: International Coalition of Medicines Regulatory Authorities (ICMRA) Executive Committee Meeting
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: ICMRA members

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/14/2021
Location: Virtuak
Subject: COVID-19 Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the State and Territory Alliance for Testing Vaccination Action Network Weekly Roundtable

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 07/14/2021
Location: Virtual
Subject: Bank of America 2021 Washington DC Health Care Conference; Speaker: CDRH Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Institutional investors and mutual fund managers

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 07/15/2021
Location: Virtual
Subject: Drug Discovery and Development Colloquium; Speaker: Welcoming Remarks
FDA Participant/Group: WEIDA TONG; SHRADDHA THAKKAR;
Non FDA Participant/Group: Government, industry, academia, and other invited guests

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top